were used to evaluate the existence of symptom subtypes using latent class analysis.
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S o c i e t y Introduction
Obstructive sleep apnea (OSA) is a common, chronic condition associated with multiple adverse outcomes (1) , with increased prevalence concomitant with increasing obesity rates (2) . Currently, OSA severity is primarily characterized by the apneahypopnea index (AHI), i.e. the number of cessations (apneas) or reductions (hypopnea) in breathing per hour of sleep (3) . Using the AHI, mild sleep apnea is defined as between 5-15 events/hour, moderate OSA as between 15-30 events/hour, and severe disease as AHI≥30 events/hour. However, these severity definitions are somewhat arbitrary, as they are based on consensus rather than using data about specific clinical outcomes (3).
Moreover, this characterization only captures one aspect of disease heterogeneity among patients (4).
To better characterize individual OSA patients, recent studies have been undertaken to evaluate disease subtypes (4) (5) (6) (7) (8) . In particular, our group has focused on the identification, replication and validation of subtypes based on clinical symptoms at diagnosis among patients with moderate-severe OSA within both clinical (5, 6 ) and population-based samples (7) . Through these efforts, we have consistently identified three primary subtypes characterized by (a) disturbed sleep (i.e., insomnia) symptoms, (b) a relative lack of traditional OSA symptoms, or (c) marked excessive daytime sleepiness. Beyond these, analyses in the Sleep Apnea Global Interdisciplinary Consortium (SAGIC), a worldwide ethnically diverse sample of OSA patients from sleep clinics, identified two additional subtypes characterized by either upper airway symptoms or moderate sleepiness (6) . Ultimately, the consistency of these results provides strong
A m e r i c a n J o u r n a l o f R e s p i r a t o r y a n d Positive Airway Pressure (CPAP) (9) . Currently, however, it is unknown whether these symptom subtypes have different long-term health consequences, particularly with respect to cardiovascular disease.
To address this question, the present study utilizes data from the Sleep Heart Health Study (SHHS). This highly successful community-based study has established the association between sleep apnea and a number of different cardiovascular outcomes (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) . Using this resource, we first leverage information on baseline symptoms to determine whether the previously described clinical subtypes exist in OSA patients from the SHHS. After validating the existence of similar subtypes, we next assess whether different subtypes are associated with prevalence of cardiovascular diseases at baseline and risk of incident cardiovascular outcomes during the follow-up period, when compared both to other subtypes and to individuals without OSA (AHI<5).
Methods

Study Participants
The SHHS is a multi-center prospective community-based cohort study of participants aged >40 years from ongoing epidemiological studies, assessing the cardiovascular consequences of OSA (22, 23) ; see online data supplement for details. 
Cardiovascular outcomes and covariates
Our primary outcome was cardiovascular disease (CVD), defined as ≥1 event of coronary heart disease (CHD), heart failure (HF), stroke (13, (26) (27) (28) or cardiovascular mortality (incident analysis only). Individual components were evaluated separately as secondary outcomes. CHD was defined as ≥1 event of myocardial infarction or coronary revascularization procedure (14) . Stroke was defined according to previously reported protocols (15) . Cardiovascular mortality included death from CHD, sudden death, or stroke (19) . Prevalent or incident disease was defined as the occurrence of ≥1 event before baseline or between baseline and the end of the follow-up, respectively. Time to
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Statistical analysis
A latent class analysis (LCA) was performed among moderate-severe OSA patients (AHI≥15) using 14 symptom questions plus the Epworth Sleepiness Scale (ESS) (31) , reflecting questions similar to prior publications on symptom clusters (5-7, 9) (see Table E1 ). The number of clusters with the lowest Bayesian Information Criterion value was considered optimal and evaluated for clinical interpretations and follow-up analyses.
Associations between OSA subtypes and prevalent outcomes were assessed using logistic regression. Kaplan-Meier survival analysis and Cox proportional hazards models were used to evaluate associations with incident outcomes, excluding participants with the corresponding disease at baseline. We performed sensitivity analyses excluding (a) individuals with central apnea index ≥2.5 events/hour (Table E3 ) or (b) individuals with any prevalent CVD ( Table E4) . Associations were evaluated unadjusted (see Table E5 ) and adjusted for covariates described above. We also evaluated associations between subtypes and either incident or recurrent events, including all available individuals and adjusting for prevalent disease.
A m e r i c a n J o u r n a l o f R e s p i r a t o r y a n d Figure E2 ). Figure 1 shows the relative proportion of each symptom, and average ESS scores, across the symptom subtypes.
Results
Sample characteristics
Based on the distribution of observed symptoms, the subtypes were labeled as Disturbed A m e r i c a n T h o r a c i c
S o c i e t y
We investigated whether the different symptom subtypes were associated with prevalent CVD and its components (CHD, HF and stroke) in individuals with OSA, controlling for conventional cardiovascular risk factors. We found significant associations ( Results of the logistic regression models are shown in Table 2 . In adjusted models, no significant associations with CVD were found. Among secondary outcomes, we observed an association between symptom subtype and prevalent HF (p=0.015), which was significant at a Bonferroni-corrected threshold (p<0.0167). In between group comparisons ( Given the known relationship between HF and central sleep apnea (32), we also performed a sensitivity analysis excluding individuals presenting with a central apnea index ≥2.5 events/hour. Results were similar, with potentially stronger effects of the association between the Excessively Sleepy subtype and prevalent HF based on OR estimates (see Table E3 ).
A m e r i c a n J o u r n a l o f R e s p i r a t o r y a n d Results from adjusted Cox proportional hazards are summarized in Figure 3 and Table 2 , and demonstrate significant associations between symptom subtypes and CVD (p=0.0001). Individuals in the Excessively Sleepy subtype were at increased risk of new onset CVD when compared to each of the three other symptom subtypes ( We also evaluated the associations between OSA symptom subtypes and risk of either incident or recurrent cardiovascular events, including individuals with the corresponding cardiovascular outcome at baseline ( Table 2) . In adjusted analyses, we found a significant association between symptom subtype and incidence or recurrence of CVD (p=0.016). The Excessively Sleepy subtype had a greater risk for incident or recurrent CVD compared to each of the other subtypes, with hazard ratios (95% CI) of A m e r i c a n J o u r n a l o f R e s p i r a t o r y a n d (Table   E6) . Results from adjusted Cox proportional hazards survival models comparing symptom clusters to individuals without OSA are summarized in Figure 5 and Table E6 .
We A m e r i c a n J o u r n a l o f R e s p i r a t o r y a n d A m e r i c a n T h o r a c i c The prevalence of excessive daytime sleepiness has also been associated with increased mortality in individuals with OSA, in both the Cardiovascular Health Study (37) and research from our group in older adults (38) . However, in the current study, we did not find significant associations between the Excessively Sleepy subtype and cardiovascular mortality. This is possibly due to the limited number of cardiovascular mortality events among individuals with OSA in our study (N=90). Nevertheless, a recent study, also in the SHHS, found that short respiratory event duration, rather than AHI, independently predicted all-cause mortality in both men and woman (39) . This suggests that other definitions of OSA severity, not based on the AHI, might be more specific to inform A m e r i c a n J o u r n a l o f R e s p i r a t o r y a n d Complementary to our findings on the Excessively Sleepy subtype, our results suggest that the Disturbed Sleep subtype could be at reduced risk for incident or recurrent stroke when compared to other subtypes. In a previous study in the SHHS, a significantly increased risk of stroke with increasing quartiles of obstructive AHI was found among men, but not women (15) . Also, women with higher arousal indexes had reduced incidence of stroke (15) . In the present study, the Disturbed Sleep subtype had the highest proportion of women, which may help explain this result. While intriguing, the associations with stroke should be interpreted with some caution, given the relatively low incidence (60 events among individuals with OSA), which results in wide 95% confidence intervals, and, thus, less reliable effect estimates.
The present study highlights the importance of considering different symptombased OSA subtypes when designing future studies assessing the cardiovascular benefits of CPAP treatment. For example, the RICCADSA study, a randomized trial in individuals with severe OSA who were not excessively sleepy, found no cardiovascular benefit of CPAP (40, 41) . A much larger study in patients with known cardiovascular disease, the SAVE trial, also found no difference in the rates of future cardiovascular events between patients randomized to CPAP or no treatment for OSA (42) . The SAVE trial found the same negative results within subgroups with different degrees of daytime sleepiness.
However, due to ethical concerns associated with not treating sleepy patients as a results A m e r i c a n T h o r a c i c
subtype and in the present study, the average ESS in this subtype was 13.7 and 39.3% of patients had ESS≥15. Thus, many of the patients at greatest OSA-related cardiovascular risk may have been excluded from previous randomized trials. Given their higher risk of OSA-related cardiovascular events, excluding excessively sleepy patients from randomized trials will limit the ability to detect beneficial treatment effects, and may be one explanation for previous negative studies.
Ultimately, the increased cardiovascular risk among the Excessively Sleepy subtype in our study suggests that future trials of the cardiovascular benefit of CPAP
should not exclude subjects with excessive sleepiness. Rather, studies should focus on these patients, who are likely to show the largest benefit. There are, however, both practical and ethical concerns regarding randomization of excessively sleepy individuals to receive no specific OSA treatment, given the impact of sleepiness on both quality of life and motor vehicle crash risk (43) . A possible alternative is to employ a pragmatic design using techniques such as propensity score matching to allow causal inferences within the context of observational studies that include measures of CPAP treatment adherence (44) . Although this type of design can effectively overcome the ethical concerns of randomization, it is not without its own challenges, as it requires a robust set of relevant covariates for matching, and assumes that these covariates adequately explain the known association of adherence with cardiovascular outcomes that is independent of the effects of treatment per se (45) (46) (47) .
The finding of increased cardiovascular risk among only certain OSA symptom subtypes complements a recent study on 'physiological subtypes' (4). In particular,
Zinchuk et al have identified seven subgroups based on standard physiological data from
A m e r i c a n J o u r n a l o f R e s p i r a t o r y a n d A m e r i c a n T h o r a c i c S o c i e t y the overnight sleep study (4) . Only two of the subtypes, one with mild OSA but a high rate of period limb movements in sleep ("PLMS") and one with severe OSA ("hypopnea and hypoxia"), had evidence of cardiovascular benefits from CPAP (4). Notably, the "hypopnea and hypoxia" subtype had significant OSA and the highest average ESS (4), and thus may share underlying pathways to cardiovascular disease with the Excessively Sleepy subtype described here. Understanding the physiological basis for the different clinical symptom subtypes remains an area for future investigation.
Our study has limitations. Analyses included individuals with AHI≥15, and thus results may not generalize to individuals with less severe disease. This AHI threshold was chosen since prior research in symptom subtypes has focused exclusively on moderatesevere OSA; it also assures significant disease-related burden within the population being studied. The existence and cardiovascular relevance of symptom subtypes in mild OSA should be addressed in future investigations. Similarly, the SHHS is a relatively older-aged cohort, and thus results may not generalize to younger individuals, in whom the OSArelated cardiovascular risk might be greater (14) . Adjustment for more refined covariate measurements, such as fat distribution and other cardiovascular risk factors (e.g. diet, exercise), would have provided more robust estimates of underlying risk. Given differences in the inclusion/exclusion criteria and in outcome adjudication methods of the SHHS parent cohorts, it is plausible to expect cohort effects on the reported associations. However, in primary analyses assessing the relationship between sleep apnea and incident CHD and HF, no significant cohort effects were found (14) . Moreover, the inclusion of race and ethnicity as covariates is expected to indirectly account for site differences, as noted in a previous publication (14) . The lack of accurate CPAP therapy data is a limitation. However, respective subtype, as has recently been done in chronic obstructive pulmonary disease (48) . While this analysis is best performed across multiple samples, particularly in patients presenting to sleep clinics, our results (see Figure 1 ) suggest that complaints of feeling sleepy during the day, not feeling rested upon waking up, often feeling physically tired and a high ESS score will likely distinguish patients with the Excessively Sleepy subtype.
In conclusion, this study demonstrates that different symptom subtypes of OSA previously described in multiple cohorts (5-7) are also found in the SHHS. We show for 
Acknowledgments
We would like to acknowledge the participants that took part in this study, the National
Sleep Research Resource and the support team behind it, as well as the Sleep Heart
Health Study. We also would like to acknowledge the members of the Sleep Apnea Global
Interdisciplinary Consortium (SAGIC) for the discussion of these findings and help with interpretation of the results.
A m e r i c a n J o u r n a l o f R e s p i r a t o r y a n d A m e r i c a n T h o r a c i c S o c i e t y performed using each subtype as the reference group. The hazard ratio (HR) represented in the x-axis is shown in the log scale. More detailed results are presented in Table 2 . The
Excessively Sleepy is the only subtype at increased risk for incident CVD, CHD and HF. A m e r i c a n J o u r n a l o f R e s p i r a t o r y a n d heart failure (HF), stroke and death from CVD grouped by obstructive sleep apnea symptom subtype. The log-rank test was used to compare the survival distribution across subtypes. There were suggestive differences in CVD and trending differences in CHD survival curves among symptom subtypes.
A m e r i c a n J o u r n a l o f R e s p i r a t o r y a n d Table 2 . The Excessively Sleepy is the only subtype at increased risk for incident CVD, CHD and HF.
A m e r i c a n J o u r n a l o f R e s p i r a t o r y a n d Table E6 , in the online data supplement. The Excessively Sleepy subtype is at increased risk for incident CVD, CHD and HF when compared to individuals without OSA.
